Complex coronary cases
IVUS Guided PCI of Distal LM Bifurcation Lesion – July 2015
Views 1021

79 year-old male with hepatitis, cirrhosis and prior PCI of RCA in remote past, presented on June 12, 2015 with new onset CCS Class III angina and dyspnea. A stress MPI revealed 2mm ST-seg depression, but normal myocardial perfusion. Patient underwent Cath revealing distal left main bifurcation with prox LAD and circumflex disease with normal LV function and SYNTAX Score of 26. Heart Team discussion declined CABG due to cirrhosis. Now planned for IVUS guided PCI of distal left main bifurcation lesion.

50:51

Q&A
Q
Do you feel that the results of CANARY and of your Imaging paper will contribute to getting FDA approval for OCT or NIRS?
A.

OCT presently is approved by most of the major insurance careers and is approved on the Ambulatory basis (just like FDA). For inpatients it is part of the PCI DRG. On the other hand NIRS is not reimbursable and these two trials do not make the strong case for its approval. CANARY trial showed that we could not prevent Procedural MI even in large LCBI lesions and Dr Kini's paper showed that it is the plaque cap thickness detected on OCT more then LCBI on NIRS which causes procedural MI.


Q
In light of your recent publications, is there still a niche indication for NIR spectroscopy?
A.

NIRS still remains an investigational tool and can not be used clinically in our decision making.


Q
If we have confirmatory data of TCFA by OCT, should the TCFA segment be stented prophylactically?
A.

Actually few small trials using both IVUS and NIRS are looking into this hypothesis; that will there be benefit of stenting (especially with Absorb BVS) of these high risk thin cap nonobstructive plaques with high LCBI. Hence we need to wait for the results of these studies (SECRET, PROSPECT II- ABSORB).


Q
Where does Cangrelor fit for reducing peri-procedural MI?
A.

Cangrelor will fit synergistically with Bivalirudin use especially in STEMI cases. It will be useful in Pts where preloading of P2Y12 receptor could not be achieved or is awaited to know the coronary anatomy. It will be very useful as the bridge therapy for Pts undergoing non-cardiac surgery within 6 months of high risk DES implantation.


Q
In the NY state database, what is the incidence of peri-procedural MI at Mount Sinai Heart?
A.

At Mount Sinai incidence of peri-procedural MI is 3.2% if CK-MB > 5X is considered and 1.4% if > 10X is considered. NY state now do not track peri-procedure MIs and only tracks trans mural MIs post procedure.


Q
Overall, is SKS your preferred strategy for bifurcating LMCA?
A.

For distal LM bifurcation stenting SKS is the preferred approach, if both branches have the obstructive lesion and are >2.75mm size.


Q
In what situations will you overlook the contributory effects of downstream lesions and use FFR for LMCA?
A.

FFR for assessment of LM lesion will be useful in ostial lesions and where IVUS is difficult or can not be advanced.


Q
Is your IVUS use decreasing for LMCA?
A.

We do about 10% IVUS guided PCI of LM and that number has been constant for last 10 years.


Q
What do you consider the best three indications in 2015 for OCT?
A.

best 3 indications of OCT in 2015 are: 1) to identify the exact cause of stent thrombosis 2) to identify the lesion morphology in nonobstructive lesions in STEMI Pts 3) to evaluate the optimal Absorb BVS deployment and at follow up evaluating its resorption.


Q
Would you do this LMCA case via wrist access?
A.

Yes we have done LMCA PCI trans- radially in cases of limited peripheral access. TRI still only makes <5% of our LM PCI compared to 20% of non-LM PCI.


comments

Leave a Reply

Your email address will not be published. Required fields are marked *

suggestion
Suggestions
Staged PCI of RCA multilayer DES CTO ISR using rotational atherectomy and IVBT – November 2020
Views 266

Case and Plan: 65-year old male with known long standing history of chronic ischemic heart disease requiring multiple PCI’s over the years after declining CABG, presented with CCS Class III angina and high risk stress MPI for multivessel ischemia. A Cardiac Cath on September 28, 2020 revealed 3 V CAD: 100% proximal RCA due to […]


Complex Multivessel PCI in a High SYNTAX Score Patient – October 2020
Tags: | |
Views 346

Case and Plan: 74-year-old obese male on HD presented with CCS Class II angina and positive SPECT MPI on July 14, 2020 done as pre-op for renal transplant revealing moderate apical, inferior and inferolateral ischemia. A Cardiac Cath on August 20, 2020 revealed 3 V CAD: 70% mid RCA, 100% RCA-AV Cont, subtotal calcified mid-distal […]


Radial PCI of Long Complex Calcified LAD post TAVR – September 2020
Views 270

Case and Plan: 78 year-old-male presented on August 7, 2020 with progressive exertional dyspnea, NYHA class III. Workup revealed severe AS (AVA 0.7cm2), normal LV function and STS mortality of 1.1%. After heart team discussion, patient underwent successful TAVR using 26mm SAPIEN-3 Ultra with excellent results, AV area of 2.0cm2 and no PVL. A coronary […]


Stent Ablation with RA of Underexpanded Multilayer DES – August 2020
Tags: | |
Views 442

63 year-old male with known CAD, CABG x2 (1999) and multiple PCI’s to SVG to RCA and LCx branches presented with CCS Class IV angina and non-STEMI (TnI 1.2U). A Cardiac Cath on June 22, 2020 revealed patent LIMA to LAD, non obstructive LCx branches with patent prior stents and 90% multilayer in-stent restenosis of […]